Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000544787 | SCV000657808 | likely benign | Charcot-Marie-Tooth disease type 2 | 2024-10-24 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000776320 | SCV000911653 | likely benign | Cardiomyopathy | 2018-10-08 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001702808 | SCV002496941 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | LMNA: BP4, BP7 |
Ambry Genetics | RCV002413637 | SCV002714979 | likely benign | Cardiovascular phenotype | 2019-03-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV003999469 | SCV004826818 | likely benign | Primary dilated cardiomyopathy | 2023-12-13 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001702808 | SCV001929207 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001702808 | SCV001970247 | likely benign | not provided | no assertion criteria provided | clinical testing |